(Received for publication 17 July 1972) There exist in immunocompetent individuals two major groups of lymphocytes as defined by origin and function (see 1, 2) . One group, the non-thymus-processed (B) I lymphocytes, have in their lineage the capacity to synthesize humoral antibodies (3) . "Ihymus-processed (T) lymphocytes, on the other hand, have never been found to produce humoral antibodies to any significant degree (4) , but can be shown to function as helper cells for B cells when the latter are switched into antibody formation against several types of antigen (5) . Both B and T lymphocytes can be shown to carry immunological specificity (6, 7) . Whether this is identical or not is still unknown.
Controversy exists as to whether T and B lymphocytes can use the same generator of diversity for creating antigen-reactive cells. According to some investigators there are no detectable immunologlibulin structures of classical type on T cells (8) , whereas others report IgM-like molecules on the outer membrane of T lymphocytes (9) (10) (11) (12) . Making the assumption that B and T lymphocytes use the same genetic system for the creation of antigen-reactive cells, it would seem likely, in view of recent data supporting the germ line theory for explaining antibody diversity (see 13) , that the two groups of cells should show similar spectra of reactivity. In accordance with this, studies on cross-reacting albumins suggest that T and B lymphocytes would react with the same structures on the protein antigens (14, 15) . On the other hand, using the small peptide hormone glucagon, results obtained showed a region of the molecule as a predominant T cell activator and another site as the epitope against which most B cell products (= humoral antibodies) were directed (16) . Specificity differences of immune cells, responding either by DNA synthesis or by antibody production have been demonstrated also through the use of a cellular immunoadsorbent technique (17) . Dissimilar patterns of cross-reactivity of humoral antibodies and cellular immune responses have recently been observed by several groups (18) (19) (20) (21) (22) .
We have approached the problem of recognition of antigen by B vs. T lymphocytes by using hapten-carrier systems, allowing the investigator to distinguish between T and B cell activity against the same molecule (1, 23, 24) . Bovine serum albumin (BSA) and its methylated derivative (MBSA) were compared for their ability to induce BSA-specific antibody-forming cell precursor (AFCP, B) or helper (T) activity. It has been shown that mice immunized with methylated albumins preferentially develop delayed hypersensitivity, whereas the native albumins induce both Arthus reaction and delayed hypersensitivity (25) . Our results demonstrate that while methylation of BSA drastically reduces the B cell response against BSA, the T cell response is unaffected as tested in quantitative assays. The experiments exclude that this is due to a changed likelihood per se of MBSA to make contact with B lymphocytes but would rather suggest different recognition systems for antigen on B and T lymphocytes.
Materials and Methods
Antigens. (26) , which allows a practically complete esterification of the carboxyl groups in the absence of any other esteriflcation. 1 g of albumin, suspended in 100 ml of absolute methanol, was incubated after the addition of 1 ml of concentrated hydrochloric acid for 4 days at room temperature. It was then dialyzed against distilled water and equilibrated with balanced salt solution (BSS). The preparations were subsequently kept frozen at --20°C.
Hapten-carrier conjugates were synthesized using either sulfanilic acid (sulf) or NIP (4-hydroxy-3-iodo-5-nitrophenylacetic acid) as haptenic groups. Coupling reactions and determinations of the number of hapten groups bound per protein molecule were performed as described (24, 27, 28) . The conjugates used were: sulfs-BSA, sulfs-OA, sulf12-CGG, sulfl..,-MBSA, sulfg-HSA, sulfs-MHSA, NIPT-BSA, NIP3-OA, and NIPg-MBSA.
MBSA and BSA have been compared in vitro with respect to their reactivity with anti-BSA antibodies. In passive hemagglutination inhibition studies the sulf conjugates of BSA and MBSA have been compared as inhibitors, since unconjugated MBSA interfered with the agglutination reaction at concentrations >10 -7 M because of its positive charge. As can be seen from Fig. 1 , sulf-MBSA inhibited the BSA-specific agglutination only at much higher concentrations than sulf-BSA (a factor of 300 at 50% inhibition).
Animals, Immunization, and Cell Transfer.--Adoptive secondary anti-sulf responses were investigated in DBA/2 )< C57BL/6 mice. High responsiveness to sulf seems genetically linked to H-2 a (H. Seiler, V. Schirrmacher, unpublished data). 2 CBA mice were used to stud), anti-NIP responses. Donor mice were primarily immunized with 100/zg of antigen emulsified in complete Freund's adjuvant (Difco Laboratories, Inc., Detroit, Mich.) and administered subcutaneously into the footpads of the hind legs and in the flanks (total volume 0.2 ml). Rubin, B. 1972 . The immune response against hapten-autologous protein conjugates in the mouse. I. Specificity of antibodies produced during the primary response against dinitrophenylated mouse serum albumin. Manuscript submitted for publication. Immune cell suspensions of donor mice were prepared from their spleens and lymph nodes (popliteal, inguinal, and axillary) by pressing them through a stainless steel mesh. Single cell suspensions in BSS were prepared, washed, and counted for number and viability using trypan blue. Varying numbers of viable cells (indicated in each experiment) were transferred together with antigen intravenously into recipient mice of the same strain. These had previously been X-irradiated (29, 30) with 500 R on the same day. 10 days later the mice were bled from the retroorbital plexus and the individual sera titrated for their antibody content.
Serology and Statistical Analyses.--Anti-BSA and anti-sulf antibody titers were determined by passive hemagglutination using sheep erythrocytes coated with BSA by glutaraldehyde 2 or directly coupled with sulf as described previously (31) . All hemagglutinatlon titers reported here were resistant to reduction with 0.1 ~ 2-mercaptoethanol. Anti-BSA titers could be inhibited by BSA at about 10 "~ M (Fig. 1 ) and anti-sulf titers by sulfanyl-N-chloracetyl-Ltyrosine (32) at about 10 -7 ~i.
Binding capacities were determined for anti-NIP and anti-BSA anfisera in a modifed Farr ammonium sulfate precipitation assay by using l~SI-labeled NIP-e-aminocaproic acid (aminocap-N t~sIP) as hapten (27) or BSA-1125 (30) . All binding data indicate micrograms of hapten or antigen bound per milliliter of serum. They were calculated from the serum dilution at which 50% of the hapten/antigen in the incubation mixture (0.001 ~g/ml aminocap-N125Ip or 0.05 ~g/ml BSA-125I) was bound.
Serum antibody values were logarithmically transformed and means and standard errors were calculated. In some experiments, determination of the "intragroup" variance was carried out using all data of a given experiment. Use has been made of this variance to calculate the difference (d) that would be significant (P = 0.05) in a Student's t test between two of the experimental groups in this experiment.
Experimental Design.--The aim of the present study was to compare the specificities of antigen-specific receptors on AFCP (B) and helper (T) lymphocytes. According to the coophemoo I00 eration hypothesis (1, 5, 24) , the induction of antibody synthesis against a thymus-dependent antigen requires an interaction of both AFCP and helper cells. It is, therefore, important to establish a system where at least one of these cell types can be tested separately. The adoptive cell transfer system outlined in Fig. 2 was used for this purpose. This allows the helper cells to be tested independently by their capacity to cooperate with hapten-specific AFCP cells in a secondary anti-hapten response.
Immune In Table II secondary anti-sulf response. In this experiment BSA and MBSA have been used also as secondary carriers for the sulf hapten (for reactivity of sulf-BSA and sulf-MBSA with anti-BSA antibodies see Fig. 1 ). The carrier specificity of the adoptive secondary anti-sulf response is shown in the first three groups. Very similar cooperative anti-sulf responses were obtained when BSA or MBSA immune cells were transferred together with sulf-OA immune cells and stimulated either with sulf-BSA (groups V and VIII) or sulf-MBSA (groups VI and IX). Despite this similarity in helper activity, the AFCP activity of the BSA and MBSA immune cells seemed to be quite different. The anti-BSA titers in groups V and VIII differ by about five log2 units. A reduction of secondary anti-BSA titers can be seen also between groups V and VI and between groups VIII and IX.
In order to obtain more detailed information about helper and AFCP activity in BSA and MBSA immune cell suspensions, limiting dilution assays were carried out in two further experiments listed in The experiments reported so far do not answer the question of whether MBSA induces specific helper cells or exerts its activation of helper function in a nonspecific way, e.g., due to its positive charge it might perhaps induce cells to produce a factor substituting for carrier-specific helper cells. The helper specificity of BSA and MBSA immune cells was investigated (Table IV) . The anti-sulf responses in groups VI-IX demonstrate that MBSA as well as BSA immune cells have a helper activity specific for BSA but not HSA (for crossreactivity between BSA and HSA see Fig. 1 ). When MBSA and MHSA were taken as secondary carriers (groups X-XIII) a cooperative anti-sulf response was obtained only with the former. Apart from confirming the BSA specificity of the helper cells, these results indicate that the methylation procedure has not introduced into the albumin molecules new determinants which cross-react on the helper level. On the antibody level no new determinants could be detected either (25) .
Threshoht Dose for the Aclivalion of BSA-Specific Helper Cells by BSA or MBSA.--The
comparison of BSA and MBSA immune cells showed that MBSA had a reduced ability to react with BSA-specific AFCP cells, whereas there was no reduction of its ability to react with BSA-specific helper cells. One could argue that in the experiments reported the antigen doses were too high to allow a detection of a difference between the reactivity of BSA and MBSA at the helper level. Therefore the threshold doses for the activation of (Table V) and (b) for reactivity with the helper cells in a cooperative secondary anti-hapten response (Table VI) . Table V The threshold dose of BSA and MBSA as secondary carriers in a cooperative secondary anti-NIP response with BSA-specific helper cells was determined in the experiment shown in Table VI . NIP-BSA and NIP-MBSA did not induce a cooperative anti-NIP response at a dose of 1/~g (groups IV and VI) but did so at 10 #g (groups V and VII). The latter responses were as high as the homologous response (group I). This demonstrates that the ability of BSA to react with BSA-specific helper cells was not affected by the methylation procedure. This finding was confirmed in the secondary anti-sulf response. Sulf-OA immune cells were transferred alone or together with BSA immune cells into recipient mice which were stinmlated with different amounts of either sulf-BSA or sulf-MBSA. As shown in Fig. 3 the dose-response curves were rather similar, the one obtained with sulf-MBSA being shifted to lower antigen concentrations. The latter observation could be explained by a higher intrinsic immunogenicity of sulf-MBSA compared with sulf-BSA, since it induced a higher anti-sulf response also in the absence of BSA-specific helper cells (compare the heterologous responses in Fig. 3) . Thus, in none of the systems tested (lid BSA-specific helper cells react less well with MBSA than with BSA.
DISCUSSION
In the present article we have presented evidence that methylation of BSA to more than 95 % reduces its ability to react with anti-BSA antibodies (Fig. 1) and with BSA-specific AFCP (B) cells. However, its reactivity with BSA-specific helper (T) cells remains unchanged, as demonstrated by an identical threshold concentration of BSA and MBSA for activation of helper cells. The differential effect of methylation could be shown on two levels: (a) for the primary induction of BSA-specific AFCP or helper cells by BSA and MBSA, respectively, and (b) for the secondary interaction of BSA-specific AFCP or helper cells with hapten-BSA and hapten-MBSA conjugates.
The two main entities upon which valid interpretation of our data depend are the types of immune cells involved in the cooperative cell transfer system studied and the impact of the methylation of BSA on its physicochemical properties, which could affect its recognition by AFCP and helper cells.
The experimental evidence identifying helper cells as T and AFCP as B cells may be summarized as follows: (a) Educated thymus cells substitute for carrier-specific helper cells (1, 33) , whereas anti-carrier antibody does not, at least in conventional hapten-carrier systems (1, 24) . amine the impact of the methylation of BSA on its physicochemical properties which could influence cellular recognition. Since the methylation reaction involves only the negatively charged carboxyl groups of the molecule (26) , the most pronounced effect of the chemical modification is an alteration of charge. In agarose electrophoresis at pH 7.2 BSA moves to the positive, MBSA to the negative electrode, whereas sulf-MBSA is neutraI? One could therefore try to attribute the differential reactivity of BSA-specific AFCP and helper cells with MBSA to its altered charge. There are two arguments against this assumption: (a) the differential reactivity of BSA-specific B and T cells with MBSA is also observed when MBSA is presented as a neutral sulf-MBSA conjugate, and (b) chemical modifications at the positively charged amino groups of BSA (e.g. acetylation) had a similar effect as the methylation. ~ An alternative explanation for the poor humoral anti-BSA response induced by MBSA would be that MBSA as a consequence of a change in physicochemical properties is less likely in vivo to interact with any kind of B lymphocytes than native BSA. Arguments against this interpretation come from the results obtained when having the hapten on BSA or MBSA as secondary carriers in cooperative cell transfer systems using graded doses of antigen for secondary stimulation. Here, the anti-hapten response would require the hapten-carrier complex to come in close physical contact with the B lymphocyte immune to the hapten determinant. The results demonstrate no difference between hapten-BSA and hapten-MBSA conjugates in such tests, thus excluding the possibility that MBSA is in itself different from BSA with regard to making physical contact to B lymphocytes.
Having so far argued against unspecific factors which could have influenced our results, we must consider the possibility that B and T lymphocytes may have different or largely nonoverlapping spectra of inducing antigenic specificities. Glucagon has been shown to carry on its carboxyl end a T cell-inducing site whereas humoral antibody is directed primarily against epitopes at the amino-terminal piece (16) . Recent data from other groups (21, 19 ) support our observations with methylated BSA, in so far as they also demonstrate a differential effect of chemically modified proteins (i.e. acetoacetylated flagellin and reduced S-carboxymethylated lysozyme) on their ability to induce humoral and cell-mediated immune responses. It is tempting to speculate on the fact that all these modifications exert their effect in the same direction, namely suppression on the AFCP level. This seems to hold true also for complex cellular antigens such as sheep red blood cells (22) , an observation which hopefully will have practical implications, e.g., in tumor therapy. In some systems the suppressive effect on the antibody level is accompanied by an even enhanced ability of the modified antigen to induce cell-mediated imnmnity (21, 22) . These data in combination with our results would suggest that T cells can recognize other structures on a macromolecule than can B ceils (with some structures recognized by both), whereas work on cross-reacting albumins has yielded results suggesting similarity if not identity between T and B cell receptor specificities (14, 15) .
At this point it should be realized that recognition with regard to T or B cell activation by antigen involves at least two steps, actual specific combination between antigen-binding receptors on the cell surface with antigen plus a relatively nonspecific activation process characteristic for the cell type involved (37) . That such a latter switch-on process might be highly typical for one of the two groups of lymphocytes is shown by studies on mitogens, where the mitogen can be shown to be bound equally well (e.g. phytohemagglutinin or concanavalin A [38] ) to both B and T lymphocytes. Yet, in the soluble form of the mitogen, only T cell activation will take place, whereas if the same mitogen is rendered insoluble primarily B cell activation will be seen (39) . Thus, analogies between binding of antigen to lymphocytes as a direct measure of activation might be very misleading.
However, some interpretations of the present results are possible with regard to antigen-binding receptors on B vs. T cells. MBSA will combine 300 times less well than BSA with anti-BSA antibodies (Fig. 1) , suggesting that 0.3 % of native determinants are left on MBSA. Humoral antibodies can be considered as good analogues of soluble antigen-binding receptors for at least B lymphocytes (40) and humoral antibodies should have, if anything, a better access to antigenic sites than would cell-bound receptors for antigen. The finding that, despite this, MBSA is equal to BSA with regard to inducing anti-BSA helper activity when using graded doses of antigen in primary or secondary immune systems, we consider incompatible with the idea that BSA-specific B and T cells react with the very same determinants.
Differences in specificities of B and T cells, as they are now apparent in several systems (16) (17) (18) (19) (20) (21) (22) (41) (42) (43) (44) , could mean either (a) that the recognition systems for antigen on B and T cells are principally different or (b) that they are of identical nature, only differing in the spectra of their specificities. The latter could have been affected by genetically determined unresponsiveness (the defect appears to localize preferentially either in AFCP or helper cells [see 45]) and/or by different selection mechanisms operating during ontogeny in the diversification of B and T cell specificity (46, 47) . We would favor conception a since it allows the assumption that T cells recognize larger areas on a protein molecule than do B cells. This would be a reasonable way of explaining why chemical modifications of antigens preferentially suppress humoral antibody induction against it. for their content of BSA-specific antibody-forming cell precursors (AFCP, B) and BSA-specific helper (T) cells. When MBSA immune cells were transferred together with hapten-primed cells into recipient mice which were stimulated by a hapten-BSA conjugate, their cooperative secondary anti-hapten response was as good as in case of transferred BSA immune cells. Their secondary anti-BSA response, however, was markedly reduced (reduction factor > 30). Hapten-MBSA conjugates had the same capacity to react with BSA-specific helper cells in the cooperative secondary anti-hapten response as hapten-BSA conjugates but had a reduced ability to react with BSA-specific AFCP cells. In spite of the pronounced reduction of the B cell response, MBSA had the same threshold dose as BSA for activating BSA-specific T cells.
These data suggest that B and T cells recognize different epitopes on the BSA molecule, only those recognized by B cells being affected by the methylation procedure.
